What does NUSHU X cost?
What does NUSHU X cost?
A market-wide price breakdown for smart gait analysis shoes with vibrotactile feedback
NUSHU X starts at $1,695, with different pricing options based on features and data access . However, earlier pricing reports suggest prices starting from $1,295.00 , and one user reported paying approximately 1,600 Euro (roughly $1,700–$1,800 USD depending on exchange rate) for a pair with app data downloads and replacement coverage . Price variation stems primarily from bundled care packages, app licensing, and regional distribution—not device hardware differences. For a single pair with base app access and standard support, expect $1,700–$1,800 in North America.
What the typical range is
Current public pricing falls into discrete tiers:
- Base model (shoes only, no app): $1,295–$1,400 USD / ~€1,200–€1,300
- Standard package (shoes + mobile app, single user): $1,695–$1,800 USD
- Premium package (shoes + app + quarterly expert consultations): $1,800–$2,000+ USD
- European pricing (through clinics): Approximately 1,600 Euro for app-enabled pairs
NUSHU X is available in both the U.S. and the European Union, and can be purchased through Magnes' partner clinics or directly from their online store . MedSource does not yet have institutional or bulk-purchase quotes; these are consumer direct-to-patient prices. Clinic procurement may differ based on volume and partnership agreements.
What pushes price up — features, certifications, support tier
Device status and regulatory clearance. NUSHU is certified as a Class IIa Medical Device under the EU's Medical Device Regulations (MDR) . The FDA has registered it as a Class 2 device, indicating it is safe for its intended purpose, with sufficient evidence supporting its safety . This dual regulatory footing—CE MDR + FDA Class II—supports premium positioning compared to unregulated consumer wearables.
Analytics package and app tier. The base app package includes the NUSHU X app (currently available only for iPhones or iPads), with which you can track your progress and share data with others . A premium tier includes the app and quarterly calls from an expert who can review your data . The device tracks over 40 walking parameters for better mobility insights , meaning app-enabled pricing reflects access to those detailed clinical-grade outputs.
Clinical assessment and fitting service. Magnes recommends that you try the NUSHU X to ensure that it is effective, set to the correct stimulation, and fits properly . Specialized testing-center assessments or in-home evaluations are available but typically carry additional fees not included in the shoe base price.
What pushes price down — refurbished, older generation, lease, GPO contracts
Refurbished units. No published refurbished or open-box pricing is currently available. The product is relatively new to North American direct-to-consumer distribution; secondary markets have not matured.
Care/replacement plans. If you select a replacement option, Magnes will replace your shoes with a brand-new pair after two years, and this is a good option if you see yourself using the shoes a lot, especially if you plan to wear them outside . This extended-warranty bundle increases upfront cost but spreads risk over 2 years—relevant for clinics deploying multiple pairs.
Institutional or clinic-based bulk purchasing. After three years, the NUSHU is pretty well established in Switzerland, with a typical clinic buying a dozen pairs and the cost now being covered by health insurance . Swiss clinics have integrated NUSHU into standard care at scale. No public GSA contract, group purchasing organization (GPO) agreement, or insurance reimbursement schedule has been published for the U.S. market yet.
Lease or rental models. None identified in publicly available sources. The product is sold, not leased, in current market channels.
Hidden costs — installation, training, calibration, consumables, service contracts
Shipping and delivery. Included in direct online orders; clinics may negotiate separate logistics.
User training and onboarding. Magnes recommends that you try the NUSHU X to ensure that it is effective, set to the correct stimulation, and fits properly . Professional fitting at a NUSHU Test Center is not included in shoe purchase but is strongly recommended. Test-center assessments cost an additional amount (not publicly specified) and deliver a balance and gait report as output.
App infrastructure and data hosting. With the app, you can track your progress and share your data with others . App access is included in standard and premium packages; no separate annual subscription has been disclosed. Data governance is not detailed in public materials.
Battery charging and dock. Charging requires connecting two charger pieces to each other, connecting charging cables to a power adapter, and placing shoes on the charging station . Charging station is included; replacement dock costs are not published.
Replacement shoes or insole components. The two-year replacement plan is a great option if you see yourself using the shoes a lot, especially if you plan to wear them outside . Without the plan, out-of-warranty replacement cost is undisclosed. (Please note: Nushu X is not designed for running and cannot get wet from rain, snow, or other sources) , limiting operational lifespan outdoors.
Clinical dashboard and patient data monitoring. Unclear whether clinician access to the NUSHU health dashboard (for monitoring multiple patients' gait trends) incurs a per-clinic or per-patient monthly fee. Magnes' direct-to-patient model does not transparently price this for institutional bulk deployment.
Technical support and warranty. Standard warranty terms are not publicly specified. Magnes support is available at support@magnes.ch; response times and on-site service availability are not documented.
How to negotiate — concrete tactics
-
Seek test-center trial first. Some sites operate as NUSHU X Trial Hubs where you can test the shoes prior to making a purchase, and if you decide to purchase, you will need a referral code to use on the Magnes shopping site. Magnes recommends trying the NUSHU X to ensure that it is effective, set to the correct stimulation, and fits properly . Referral codes may unlock pricing flexibility; ask trial partners about volume or clinic discounts.
-
Confirm app and data rights. Negotiate whether your clinic retains ownership of collected gait data and whether you can export datasets in standard formats (e.g., CSV, HL7 FHIR). No public data-sharing agreement or terms of service are available; request this in writing before purchase.
-
Inquire about insurance reimbursement pathways. Coverage varies by provider. Check with your healthcare plan for reimbursement options . Some clinics may have established preauthorization workflows or bundled claims codes (though none have been published). Ask Magnes for a list of insurers who have approved reimbursement.
-
Bundle with testing and training. If purchasing multiple pairs for a clinic, negotiate fixed fees for baseline gait assessments, staff training, and quarterly data review calls rather than accepting per-patient à la carte pricing.
-
Request multi-year pricing and maintenance packages. Magnes will replace your shoes with a brand-new pair after two years . For clinics planning sustained deployment, lock in 2-year or 3-year pricing upfront, including replacement and software updates.
When the price feels off — red flags
No published clinic or institutional pricing. All discoverable pricing is direct-to-consumer. If a vendor quotes you below $1,200 or above $2,400 without clear bundled services, ask for itemized scope.
Unclear data access terms. The app is "currently available only for iPhones or iPads" (no Android option disclosed). If you operate on Android or need cloud integration with an existing EHR, confirm technical compatibility before committing.
Absence of warranty details. Magnes does not publicly publish warranty length, repair coverage, or out-of-pocket replacement costs. Request written terms before purchase.
No transparency on clinic-scale deployments. If Magnes cites successful "dozen-pair clinic purchases" in Switzerland but offers no U.S. clinic reference or case study, request introductions to existing North American institutional users and ask about their negotiated terms.
Insurance coverage claims without evidence. Coverage varies by provider , but no CPT codes, reimbursement rates, or approved-payer list has been published. Claims of "insurance coverage" in marketing should be verified directly with your plan.
Sources
All About Parkinson's (March 2025): "NUSHU smart shoes are now available in both the U.S. and the European Union. They can be purchased through Magnes' partner clinics or directly from their online store. The NUSHU X model starts at $1,695."
-
Parkinson's UK Tech Guide (January 2026): NUSHU X product entry confirming Class IIa medical device status and UK sizing availability.
EIN Presswire / Magnes press release (July 2024): "NUSHU is certified as a Class IIa Medical Device under the EU's Medical Device Regulations (MDR)."
Clinical Trials registry / With Power (July 2024): "The FDA has registered it as a Class 2 device, indicating it is safe for its intended purpose, with sufficient evidence supporting its safety."
Rory Cellan-Jones (December 2024, Substack): "After three years, the NuShu is pretty well established in Switzerland, with a typical clinic buying a dozen pairs and the cost now being covered by health insurance."
-
Magnes AG official website (magnes.ch): Product pages, technical specifications, and purchasing workflows.
-
Move Up Health (California partner clinic): NUSHU X assessment and referral process documentation.
Note: This article reflects publicly discoverable pricing and feature information as of May 2026. MedSource does not yet hold aggregated institutional quote data for NUSHU X. Pricing and bundled-service terms may vary by geography, partnership status, and insurance plan. This article will be updated as vendor quote data and reimbursement precedent accrue.
MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.